Heartseed News

Heartseed: Notice of completion of safety evaluation committee review on administration of HS-001 LAPIS test high dose group first case

Oct 1 02:30 ET

Heartseed: [Delayed] Financial Results for the Nine Months Ended July 31, 2024 (Under Japan GAAP)(Non-consolidated)

Sep 13 02:30 ET

Heartseed: Independent Company Executives Declaration

Jul 29 19:45 ET

Heartseed: Articles of Incorporation 2024/04/17

Jul 29 19:31 ET

Heartseed: Heartseed announced a positive recommendation from the safety monitoring committee regarding dose escalation in Phase 1/2 clinical trials administered with HS-001.

Jul 29 19:00 ET

Heartseed: In the HS-001 LAPiS trial, the Safety Evaluation Committee recommended the start of administration in the high-dose group.

Jul 29 19:00 ET

Heartseed: Matters related to business plans and growth potential.

Jul 29 19:00 ET

Heartseed: Announcements of individual stocks regarding our financial information etc. due to our listing on the Tokyo Stock Exchange Growth Market.

Jul 29 19:00 ET

Heartseed Inc.: Confirmation letter regarding the appropriateness of securities reports for listing application.

Jun 26 04:00 ET

Heartseed Inc.: Quarterly report for IPO application (Q2)

Jun 26 04:00 ET

Heartseed Inc.: Quarterly report for initial public offering (Q1)

Jun 26 04:00 ET

Heartseed Inc.: Securities Report for Listing Application

Jun 26 04:00 ET